NanoString Technologies ( NASDAQ:NSTG – Get Rating ) had its price objective cut by equities research analysts at Morgan Stanley from $17.00 to $16.00 in a report issued on Thursday, Benzinga reports. The firm presently has an 'equal weight' rating on the biotechnology company's stock. Morgan Stanley's price objective points to a potential upside of 53.85% from the stock's current price. Several other research analysts also recently weighed in on NSTG. Cowen reduced their price target on shares of NanoString Technologies from $31.

https://www.dailypolitical.com/2023/03/04/nanostring-technologies-nasdaqnstg-pt-lowered-to-16-00.html

#dailypolitical